| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/28/2026 | ±2.4% | +2.1% | over-priced |
| 02/10/2026 | ±3.5% | -8.2% | under-priced |
| 10/28/2025 | ±2.2% | -1.5% | over-priced |
| 07/29/2025 | ±1.9% | +10.3% | under-priced |
| 04/29/2025 | ±2.4% | +1.5% | over-priced |
| 02/10/2025 | ±2.8% | -7.9% | under-priced |
| 10/29/2024 | ±1.6% | +12.0% | under-priced |
| 07/30/2024 | ±2.7% | -1.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.47 | $1.3B | $303M |
| Q4 FY2025 | — | $1.5B | $299M |
| Q3 FY2025 | $2.11 | $1.4B | $424M |
| Q2 FY2025 | $2.04 | $1.2B | $405M |
INCY (INCY) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 5.6% on average — the market has been roughly fair on INCY's earnings risk. Fundamentals into the print: EPS up 83.7% year-over-year, revenue up 20.9%. QuantLogix's live 5-factor engine currently reads INCY as a buy at 72/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →